Literature DB >> 28190165

Losartan attenuates aortic endothelial apoptosis induced by chronic intermittent hypoxia partly via the phospholipase C pathway.

Jie Ren1, Wei Liu2, Yan Deng1, Guang-Cai Li1, Yue-Ying Pan1, Sheng Xie1, Meng Jin1, Hui-Guo Liu3.   

Abstract

PURPOSE: Endoplasmic reticulum (ER) stress is known to play key roles in the development of endothelial cell apoptosis induced by chronic intermittent hypoxia (CIH), and the angiotensin II-phospholipase C-inositol-1,4,5-triphosphate (AngII-PLC-IP3) pathway has been demonstrated to induce ER stress. To explore whether the AngII-PLC-IP3 pathway is involved in the vascular damage induced by CIH, we examined whether the AngII-PLC-IP3 pathway is involved in ER stress induced by CIH and whether losartan, a selective angiotensin II type 1 receptor (AT1R) blocker, could suppress endothelial cell apoptosis induced by CIH.
METHODS: Adult male Sprague Dawley rats were subjected to 8 h/day of intermittent hypoxia/normoxia, with or without losartan, a selective AT1R blocker, and/or U73122, a selective PLC inhibitor, for 8 weeks. Endothelial cell apoptosis, ER stress markers, and levels of PLC-γ1 and IP3R expression were determined.
RESULTS: Losartan prevented increases in PLC-γ1 and IP3R protein levels and inhibited ER stress markers induced by CIH. Addition of U73122 reproduced all the protective effects of losartan. Losartan administration before CIH significantly ameliorated CIH-induced endothelial cell apoptosis.
CONCLUSIONS: This study showed that the AngII-PLC-IP3 pathway is involved in ER stress induced by CIH and that pre-losartan administration ameliorates endothelial cell apoptosis following CIH partly via inhibition of the AngII-PLC-IP3 pathway and ER stress.

Entities:  

Keywords:  Chronic intermittent hypoxia; ER stress; Endothelial cell apoptosis; Losartan; PLC-IP3 pathway

Mesh:

Substances:

Year:  2017        PMID: 28190165     DOI: 10.1007/s11325-017-1479-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  27 in total

Review 1.  ER chaperone functions during normal and stress conditions.

Authors:  Yanjun Ma; Linda M Hendershot
Journal:  J Chem Neuroanat       Date:  2004-09       Impact factor: 3.052

2.  Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.

Authors:  Noah J Marcus; Nathan R Philippi; Cynthia E Bird; Yu-Long Li; Harold D Schultz; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2012-06-21       Impact factor: 1.931

3.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

Review 4.  TRPC channels in vascular cell function.

Authors:  A Dietrich; H Kalwa; T Gudermann
Journal:  Thromb Haemost       Date:  2009-11-13       Impact factor: 5.249

5.  Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells.

Authors:  K K Griendling; S E Rittenhouse; T A Brock; L S Ekstein; M A Gimbrone; R W Alexander
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

6.  Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179.

Authors:  Tetsu Watanabe; Jun Suzuki; Hideyuki Yamawaki; Virendra K Sharma; Shey-Shing Sheu; Bradford C Berk
Journal:  Circulation       Date:  2005-09-20       Impact factor: 29.690

7.  Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors.

Authors:  I Goldenberg; E Grossman; K A Jacobson; V Shneyvays; A Shainberg
Journal:  J Hypertens       Date:  2001-09       Impact factor: 4.844

8.  Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation.

Authors:  D Li; B Yang; M I Philips; J L Mehta
Journal:  Am J Physiol       Date:  1999-03

9.  In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions.

Authors:  Cuifen Hou; Thomas Kirchner; Monica Singer; Michele Matheis; Dennis Argentieri; Druie Cavender
Journal:  J Pharmacol Exp Ther       Date:  2004-01-16       Impact factor: 4.030

10.  Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis.

Authors:  Sven Baumann; Stefanie C Fas; Marco Giaisi; Wolfgang W Müller; Anette Merling; Karsten Gülow; Lutz Edler; Peter H Krammer; Min Li-Weber
Journal:  Blood       Date:  2007-12-10       Impact factor: 22.113

View more
  4 in total

1.  Plasma Exosomes and Improvements in Endothelial Function by Angiotensin 2 Type 1 Receptor or Cyclooxygenase 2 Blockade following Intermittent Hypoxia.

Authors:  Abdelnaby Khalyfa; Nina Youssefnia; Glen E Foster; Andrew E Beaudin; Zhuanghong Qiao; Vincent Pialoux; Matiram Pun; Patrick J Hanly; Leila Kheirandish-Gozal; Marc J Poulin; David Gozal
Journal:  Front Neurol       Date:  2017-12-22       Impact factor: 4.003

2.  Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model.

Authors:  Xiao-Bin Zhang; Jing-Huang Cai; Yu-Yun Yang; Yi-Ming Zeng; Hui-Qing Zeng; Miao Wang; Xiao Cheng; Xiongbiao Luo; Henry Chidozie Ewurum
Journal:  Sleep Breath       Date:  2018-09-15       Impact factor: 2.816

3.  O‑GlcNAcylation contributes to intermittent hypoxia‑associated vascular dysfunction via modulation of MAPKs but not CaMKII pathways.

Authors:  Xueling Guo; Yan Deng; Linghui Zhan; Jin Shang; Huiguo Liu
Journal:  Mol Med Rep       Date:  2021-08-26       Impact factor: 2.952

4.  Silencing of the long non-coding RNA MEG3 suppresses the apoptosis of aortic endothelial cells in mice with chronic intermittent hypoxia via downregulation of HIF-1α by competitively binding to microRNA-135a.

Authors:  Haibo Ding; Jiefeng Huang; Dawen Wu; Jianming Zhao; Jianchai Huang; Qichang Lin
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.